SightLife™ research partnerships advance
sight restoration/cornea technology

SightLife is an active research partner with several domestic and foreign universities and biotechnology corporations. We are a core member of the Washington Biotechnology and Biomedical Association, as well as the Vision Share Eye Bank Consortium. Through research partnerships, we seek to improve outcomes for cornea transplant recipients and/or make transplants available to more people in more countries. Current research projects include:

  • IntraLase Enabled Keratoplasty. Custom Corneal Tissue™ (CCT™) prepared with a IntraLase femtosecond laser is already available from SightLife, but this may be just the beginning for this advance in cornea transplant technology. SightLife and IntraLase are now working on additional uses for the femtosecond laser tailored to specific needs of cornea transplant surgeons.
  • Grant support for corneal research conducted by Dr. Tueng Shen of the University of Washington. Our grant allows Dr. Shen to spend one day each week on research to advance the science of corneal tissue transplantation. One of her areas of exploration is whether new cornea tissue can be regenerated from existing live tissue.

Surgeons or teaching universities with an interest in establishing a research relationship with SIghtLife can contact:

Jeremy Shuman, SightLife Technical Director
206-682-8500